Research Article

Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial

Table 3

Reported use of protection methods (% of women users) in the prior six months, at baseline and followup, by partner and study arm (cross-sectional analysis).

Primary partnerBaseline12-month followup
Control
(%)
Intervention
(%)
P Control
(%)
Intervention
(%)
P

Male condom 14 (19)14 (18) 0.8214 (33)20 (42)0.20
Female condom3 (4)5 (6)0.7212 (29)9 (19)0.24
Spermicide4 (5)6 (8)0.726 (14)10 (21)0.42
Diaphragm/cervical cap03 (4)0.2571 (2)0.34

HIV-negative, non-primary partner Control
(%)
Intervention
(%)
Control
(%)
Intervention
(%)

Male condom60 (94)38 (69)0.0221 (75)16 (67)0.51
Female condom5 (8)4 (7)0.742(7)6 (24)0.13
Spermicide6 (9)7 (13)0.851 (4)5 (20)0.08
Diaphragm/cervical cap02 (4)0.470 (0)1 (4)0.46